ClinicalTrials.gg
RecruitingNCT07875738Updated Oct 15, 2026

Effect Of Orofacial Pain Therapy On Bruxism

An observational study in Masticatory Myofascial Pain, sponsored by Catholic University of the Sacred Heart. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 79 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Catholic University of the Sacred Heart · Observational

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.
Updated Oct 15, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
42
Ages
18 Years to 79 Years
Sex
All
01

Study summary

Bruxism and clenching at night and during the day are considered the most common parafunctions that can influence temporomandibular disorders, including chronic myofascial pain of the masticatory muscles. When bruxism and/or clenching are present, treatment generally includes the use of a gnathological splint at night. According to the International Consensus on Bruxism, a definitive diagnosis of bruxism/clenching requires an instrumental assessment consisting of an electromyographic recording of masticatory muscle activity. In this regard, over the past four years, an Italian company (Biotech-Novations, Sanremo, Italy) has created a portable device (dia- BRUXO) to be worn for 24 hours (day and night) that measures muscle activity in the oral region. The company has established baseline cut-off values for daytime and nighttime muscle activity. The aim of the study is to investigate the effectiveness of using gnathological splints in reducing bruxism and clenching during wakefulness and sleep in adults with chronic myofascial pain.

02

Conditions studied

  • Masticatory Myofascial Pain
03

In context

Lead sponsor

Catholic University of the Sacred Heart is the lead sponsor of 237 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

adults patients with chronic masticatory myofascial pain

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult subjects
  • Subjects who agree to sign the informed consent form
  • Patients with temporomandibular dysfunction who are indicated for treatment with a gnathological splint

Exclusion criteria

Exclusion criteria:

- Patients who change their medication regimen during the monitoring period because pharmacological therapy may affect facial pain and/or muscle activity.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
42 participants (estimated)
Patient registry
No

Groups and cohorts

  • Chronic masticatory myofascial pain
  • Healthy controls
06

What researchers measure

Primary outcomes

  1. effectiveness of gnathological splints on bruxism during wakefulness and sleep in adults with myofascial pain, measured through EMG values obtained by dia-BRUXO device. During treatment EMG values will be compared for each subject to pre-treatment EMG

    EMG-recorded masticatory muscle activity will be collected using the dia-BRUXO device; which is a tool to diagnose bruxism and clenching both during wakefulness and sleep. patients with chronic myfascial pain will undergo dia-BRUXO registration at baseline and 2 months after receiving a gnathological splint (the regular treatment for bruxism) for night time use. changes will be compared between pre and during treatment. a control group of subjects without pain will undergo the same registrations at 2 months distance, without splint use.

    Time frame: 24 months

07

Study locations

1 of 1 sites recruiting
  • Università Cattolica del Sacro Cuore
    Roma, 00168, Italy
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07875738
Responsible party
Anna Alessandri Bonetti (Principal Investigator, Catholic University of the Sacred Heart) — Principal investigator
First posted
Oct 15, 2026
Start date
Jan 16, 2026
Primary completion
Jun 30, 2027 (estimated)
Completion
Sep 30, 2027 (estimated)
Last update
Oct 15, 2026

Study contacts

Anna Alessandri Bonetti
Contact
anna.alessandribonetti@unicatt.it
+393341413280

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion